- Home
- EFSC vs RCKT Comparison
EFSC vs RCKT Comparison
Compare EFSC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSC | RCKT |
|---|---|---|
| Founded | 1988 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 340.9M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | EFSC | RCKT |
|---|---|---|
| Price | $56.65 | $3.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $65.67 | $29.12 |
| AVG Volume (30 Days) | 147.3K | ★ 2.3M |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 8.68 | N/A |
| EPS | ★ 5.13 | N/A |
| Revenue | ★ $646,694,000.00 | N/A |
| Revenue This Year | $20.14 | N/A |
| Revenue Next Year | $5.15 | N/A |
| P/E Ratio | $11.06 | ★ N/A |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $45.22 | $2.19 |
| 52 Week High | $62.60 | $13.50 |
Technical Indicators
Market Signals| Indicator | EFSC | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 52.07 |
| Support Level | $55.09 | $3.30 |
| Resistance Level | $58.25 | $3.65 |
| Average True Range (ATR) | 1.31 | 0.19 |
| MACD | 0.32 | 0.05 |
| Stochastic Oscillator | 67.44 | 66.22 |
Price Performance
Historical ComparisonAbout EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.